{"nct_id":"NCT04229979","title":"Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2021-02-08","start_date_type":"ACTUAL","primary_completion_date":"2025-12","primary_completion_date_type":"ESTIMATED","completion_date":"2026-12","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["SLS"]}